Global Non-Small Cell Lung Cancer Drugs Market 2019-2023

非小細胞肺癌治療薬の世界市場2019-2023

◆タイトル:Global Non-Small Cell Lung Cancer Drugs Market 2019-2023
◆商品コード:IRTNTR30977
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年3月16日
◆ページ数:124
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:Health Care
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥327,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、非小細胞肺癌治療薬の世界市場について調査・分析し、市場概要、市場環境、非小細胞肺癌治療薬市場規模、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・非小細胞肺癌治療薬の世界市場概要
・非小細胞肺癌治療薬の世界市場環境
・非小細胞肺癌治療薬の世界市場動向
・非小細胞肺癌治療薬の世界市場規模
・非小細胞肺癌治療薬の世界市場:業界構造分析
・非小細胞肺癌治療薬の世界市場:地域別市場規模・分析
・非小細胞肺癌治療薬の北米市場規模・予測
・非小細胞肺癌治療薬のヨーロッパ・中東・アフリカ市場規模・予測
・非小細胞肺癌治療薬のアジア太平洋市場規模・予測
・非小細胞肺癌治療薬の主要国分析
・非小細胞肺癌治療薬の世界市場:意思決定フレームワーク
・非小細胞肺癌治療薬の世界市場:成長要因、課題
・非小細胞肺癌治療薬の世界市場:競争環境
・非小細胞肺癌治療薬の世界市場:関連企業情報(ベンダー分析)

About this market
The increasing prevalence and incidence of non-small cell lung cancer are one of the primary factors driving the global non-small cell lung cancer drugs market growth. The growing risk factors such as cigarette smoking, air pollution, secondary smoking, and occupational exposure is increasing the incidence of non-small cell lung cancer across the world. This will lead to an increase in the demand for non-small cell lung cancer drugs. Technavio’s analysts have predicted that the non-small cell lung cancer drugs market will register a CAGR of over 13% by 2023.
Market Overview
Strong drug pipeline and recent drug approvals
One of the growth drivers of the global non-small cell lung cancer drugs market is the strong drug pipeline and recent drug approvals. The development of new drugs and their approvals are helpful for the treatment of non-small lung cancer, which is expected to drive the market during the forecast period.
The high cost of treatment
One of the challenges in the growth of global non-small cell lung cancer drugs market is the high cost of treatment. Non-small cell lung cancer can be treated by surgery, chemotherapy, radiation therapy, targeted therapies, and immunotherapy which is very costly. Therefore, the high cost of treatment for non-small cell lung cancer will hamper the growth of the market during the forecast period.
For the detailed list of factors that will drive and challenge the growth of the non-small cell lung cancer drugs market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be moderately fragmented and with the presence of several vendors. The vendors in the market are using predictive biomarkers for the development of cost-effective therapies with improved clinical benefits. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
• Market segmentation by application
• Comparison by application
• Asset and capacity management – Market size and forecast 2018-2023
• Energy management – Market size and forecast 2018-2023
• Power and cooling management – Market size and forecast 2018-2023
• Network management – Market size and forecast 2018-2023
• Market opportunity by application
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Middle East and Africa – Market size and forecast 2018-2023
• South America – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Increased use of analytics
• Emergence of hybrid IT infrastructure
• High adoption of IoT, in-built sensors, and edge computing
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Nlyte
• Panduit Corp.
• Schneider Electric
• Sunbird Inc.
• Vertiv Co.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global data center investments market
Exhibit 02: Segments of global data center investments market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Application – Market share 2018-2023 (%)
Exhibit 18: Comparison by application
Exhibit 19: Asset and capacity management – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Asset and capacity management – Year-over-year growth 2019-2023 (%)
Exhibit 21: Energy management – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Energy management – Year-over-year growth 2019-2023 (%)
Exhibit 23: Power and cooling management – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Power and cooling management – Year-over-year growth 2019-2023 (%)
Exhibit 25: Network management – Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Network management – Year-over-year growth 2019-2023 (%)
Exhibit 27: Market opportunity by application
Exhibit 28: Customer landscape
Exhibit 29: Market share by geography 2018-2023 (%)
Exhibit 30: Geographic comparison
Exhibit 31: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: North America – Year-over-year growth 2019-2023 (%)
Exhibit 33: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 35: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 37: Middle East and Africa – Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Middle East and Africa – Year-over-year growth 2019-2023 (%)
Exhibit 39: South America – Market size and forecast 2018-2023 ($ millions)
Exhibit 40: South America – Year-over-year growth 2019-2023 (%)
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Nlyte – Vendor overview
Exhibit 50: Nlyte – Organizational developments
Exhibit 51: Nlyte – Key offerings
Exhibit 52: Panduit Corp. – Vendor overview
Exhibit 53: Panduit Corp. – Organizational developments
Exhibit 54: Panduit Corp. – Key offerings
Exhibit 55: Schneider Electric – Vendor overview
Exhibit 56: Schneider Electric – Business segments
Exhibit 57: Schneider Electric – Organizational developments
Exhibit 58: Schneider Electric – Geographic focus
Exhibit 59: Schneider Electric – Segment focus
Exhibit 60: Schneider Electric – Key offerings
Exhibit 61: Sunbird Inc. – Vendor overview
Exhibit 62: Sunbird Inc. – Organizational developments
Exhibit 63: Sunbird Inc. – Key offerings
Exhibit 64: Vertiv Co. – Vendor overview
Exhibit 65: Vertiv Co. – Organizational developments
Exhibit 66: Vertiv Co. – Key offerings
Exhibit 67: Validation techniques employed for market sizing



【掲載企業】

AstraZeneca、Bristol-Myers Squibb Company、Eli Lilly and Company、F. Hoffmann-La Roche Ltd、Merck & Co., Inc.

★調査レポート[非小細胞肺癌治療薬の世界市場2019-2023] (Global Non-Small Cell Lung Cancer Drugs Market 2019-2023 / IRTNTR30977)販売に関する免責事項
[非小細胞肺癌治療薬の世界市場2019-2023] (Global Non-Small Cell Lung Cancer Drugs Market 2019-2023 / IRTNTR30977)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆